| LDR | | 01729nmm uu200385 4500 |
| 001 | | 000000334637 |
| 005 | | 20240805180717 |
| 008 | | 181129s2017 |||||||||||||||||c||eng d |
| 020 | |
▼a 9780438353114 |
| 035 | |
▼a (MiAaPQ)AAI10615208 |
| 035 | |
▼a (MiAaPQ)umn:18426 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 248032 |
| 082 | 0 |
▼a 574 |
| 100 | 1 |
▼a Tasca, Amy Ward. |
| 245 | 14 |
▼a The Role of Myosin X in BMPs Promotion of SMAD 1/5 in Osteoclast Formation and Function. |
| 260 | |
▼a [S.l.] :
▼b University of Minnesota.,
▼c 2017 |
| 260 | 1 |
▼a Ann Arbor :
▼b ProQuest Dissertations & Theses,
▼c 2017 |
| 300 | |
▼a 105 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 80-01(E), Section: B. |
| 500 | |
▼a Adviser: Kim Mansky. |
| 502 | 1 |
▼a Thesis (Ph.D.)--University of Minnesota, 2017. |
| 520 | |
▼a Novel therapeutic strategies that target osteoclasts are needed for many orthopedic, craniofacial and cancer applications. Incomplete understanding of the factors that regulate osteoclasts limits this development. Currently, bone morphogenetic p |
| 520 | |
▼a The data presented in this thesis demonstrates that loss of SMAD1/5 expression by osteoclasts in in vitro cultures of osteoclasts inhibits osteoclast differentiation and activity. However, the loss of SMAD1/5 expression in osteoclasts and macrop |
| 590 | |
▼a School code: 0130. |
| 650 | 4 |
▼a Biology. |
| 690 | |
▼a 0306 |
| 710 | 20 |
▼a University of Minnesota.
▼b Oral Biology. |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 80-01B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0130 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2017 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T14996630
▼n KERIS |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a 관리자 |